The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Gabriele Fragasso

Heart Failure Clinic

Istituto Scientifico San Raffaele

via Olgettina 60

20132 Milano

[email]@hsr.it

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Heart Failure Clinic, Istituto Scientifico San Raffaele, via Olgettina 60, 20132 Milano. 2004 - 2012
  • Clinical Cardiology-Heart Failure Unit, Interventional Cardiology, and Cardiac Surgery, Istituto Scientifico/Universita' San Raffaele, Italy. 2003 - 2006
  • Dipartimento di Cardiologia e Scienze Cardiovascolari-Unita' di Cardiologia Clinica, Universita' degli Studi di Milano, Istituto Scientifico/Universita' San Raffaele, Milan, Italy. 2002 - 2003

References

  1. Pathophysiologic therapeutic targets in hypertension: a cardiological point of view. Fragasso, G., Maranta, F., Montanaro, C., Salerno, A., Torlasco, C., Margonato, A. Expert Opin. Ther. Targets (2012) [Pubmed]
  2. Effect of partial inhibition of fatty acid oxidation by trimetazidine on whole body energy metabolism in patients with chronic heart failure. Fragasso, G., Salerno, A., Lattuada, G., Cuko, A., Calori, G., Scollo, A., Ragogna, F., Arioli, F., Bassanelli, G., Spoladore, R., Luzi, L., Margonato, A., Perseghin, G. Heart (2011) [Pubmed]
  3. A high carbohydrate meal yields a lower ischemic threshold than a high fat meal in patients with stable coronary disease. Fragasso, G., Montano, C., Lattuada, G., Salerno, A., Palloshi, A., Calori, G., Luzi, L., Perseghin, G., Margonato, A. Int. J. Cardiol. (2011) [Pubmed]
  4. Cardiotoxicity after low-dose chloroquine antimalarial therapy. Fragasso, G., Sanvito, F., Baratto, F., Martinenghi, S., Doglioni, C., Margonato, A. Heart. Vessels (2009) [Pubmed]
  5. Metabolic therapy of heart failure. Fragasso, G., Salerno, A., Spoladore, R., Bassanelli, G., Arioli, F., Margonato, A. Curr. Pharm. Des. (2008) [Pubmed]
  6. Modulation of fatty acids oxidation in heart failure by selective pharmacological inhibition of 3-ketoacyl coenzyme-A thiolase. Fragasso, G., Spoladore, R., Cuko, A., Palloshi, A. Curr. Clin. Pharmacol (2007) [Pubmed]
  7. New directions in the treatment of heart failure: targeting free fatty acid oxidation. Fragasso, G., Spoladore, R., Bassanelli, G., Cuko, A., Montano, C., Salerno, A., Margonato, A. Curr. Heart. Fail. Rep (2007) [Pubmed]
  8. Inhibition of free fatty acids metabolism as a therapeutic target in patients with heart failure. Fragasso, G. Int. J. Clin. Pract. (2007) [Pubmed]
  9. Effects of metabolic modulation by trimetazidine on left ventricular function and phosphocreatine/adenosine triphosphate ratio in patients with heart failure. Fragasso, G., Perseghin, G., De Cobelli, F., Esposito, A., Palloshi, A., Lattuada, G., Scifo, P., Calori, G., Del Maschio, A., Margonato, A. Eur. Heart J. (2006) [Pubmed]
  10. The anti-ischemic effect of trimetazidine in patients with postprandial myocardial ischemia is unrelated to meal composition. Fragasso, G., Montano, C., Perseghin, G., Palloshi, A., Calori, G., Lattuada, G., Oggionni, S., Bassanelli, G., Locatelli, M., Lopaschuk, G., Margonato, A. Am. Heart J. (2006) [Pubmed]
  11. A randomized clinical trial of trimetazidine, a partial free fatty acid oxidation inhibitor, in patients with heart failure. Fragasso, G., Palloshi, A., Puccetti, P., Silipigni, C., Rossodivita, A., Pala, M., Calori, G., Alfieri, O., Margonato, A. J. Am. Coll. Cardiol. (2006) [Pubmed]
  12. Nitric-oxide mediated effects of transdermal capsaicin patches on the ischemic threshold in patients with stable coronary disease. Fragasso, G., Palloshi, A., Piatti, P.M., Monti, L., Rossetti, E., Setola, E., Montano, C., Bassanelli, G., Calori, G., Margonato, A. J. Cardiovasc. Pharmacol. (2004) [Pubmed]
  13. Validation of heart and lung teleauscultation on an Internet-based system. Fragasso, G., De Benedictis, M., Palloshi, A., Moltrasio, M., Cappelletti, A., Carlino, M., Marchisi, A., Pala, M., Alfieri, O., Margonato, A. Am. J. Cardiol. (2003) [Pubmed]
  14. Short- and long-term beneficial effects of trimetazidine in patients with diabetes and ischemic cardiomyopathy. Fragasso, G., Piatti Md, P.M., Monti, L., Palloshi, A., Setola, E., Puccetti, P., Calori, G., Lopaschuk, G.D., Margonato, A. Am. Heart J. (2003) [Pubmed]
  15. Acute effects of heparin administration on the ischemic threshold of patients with coronary artery disease: evaluation of the protective role of the metabolic modulator trimetazidine. Fragasso, G., Piatti, P.M., Monti, L., Palloshi, A., Lu, C., Valsecchi, G., Setola, E., Calori, G., Pozza, G., Margonato, A., Chierchia, S. J. Am. Coll. Cardiol. (2002) [Pubmed]
 
WikiGenes - Universities